Kevin Fitzgerald - CSO & EVP, Head of Research at Alnylam Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CSO & EVP, Head of Research
Stock Symbol
ALNY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Kevin Fitzgerald - trading volume in the past year for Alnylam Pharmaceuticals, Inc.

Holdings reported by Kevin Fitzgerald for Alnylam Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 21.3K $9.85M $463.08 Nov 17, 2025 Direct
Common Stock 537 $241K $449.56 Nov 17, 2025 by Managed Account
Stock Option (right to buy) 839 Nov 17, 2025 Direct Common Stock

Transactions reported by Kevin Fitzgerald for Alnylam Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.